Bernardi, Luciano
Gordin, Daniel
Bordino, Marco
Rosengård-Bärlund, Milla
Sandelin, Anna
Forsblom, Carol
Groop, Per-Henrik
Article History
Received: 26 January 2017
Accepted: 24 May 2017
First Online: 20 July 2017
Competing Interests
: L.B. is a recipient of a grant from the Signe and Ane Gyllenberg Foundation, Helsinki, Finland. P.H.G. has received lecture honorariums from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Genzyme, MSD, Novartis, Novo Nordisk, and Sanofi, and he is an advisory board member of AbbVie, AstraZeneca, Boehringer Ingelheim, Cebix, Eli Lilly, Janssen and Novartis. L.B., D.G., A.S., M.R.B., M.B., and C.F. have no potential conflicts of interest relevant to this article.